@GinoE. The long title of the presentation tells you what it is about.
It is about how IL2 helps the Pharmo-kinetics (how the drug moves around in the body) of Azer-Cel and also IL2 addition doesn't work against safety or early efficacy.
It is not bad stuff, but it is not as if there are some secret results on efficacy or something else that will drop on the day.
They have already said what it is about.
Ann: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings, page-43
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |